Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy.

Autor: Tang, Qianqian¹ (AUTHOR), Ye, Jun¹ (AUTHOR), Zhang, Yafei¹ (AUTHOR), Zhang, Peixin¹ (AUTHOR), Xia, Guomei¹ (AUTHOR), Zhu, Jie¹ (AUTHOR), Wei, Shaofeng² (AUTHOR), Li, Xu^1,2 (AUTHOR), Zhang, Zhenhua¹ (AUTHOR) zzh1974cn@163.com

Publikováno v: BMC Infectious Diseases. 7/10/2023, Vol. 23 Issue 1, p1-13. 13p.

Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D

Autor: George S. Gherlan, Stefan D. Lazar, Augustina Culinescu, Dana Smadu, Andreea R. Vatafu, Corneliu P. Popescu, Simin A. Florescu, Emanoil Ceausu, Petre I. Calistru

Publikováno v: Tropical Medicine and Infectious Disease, Vol 9, Iss 4, p 73 (2024)

Pegylated interferon alpha 2a continues to be used for the treatment of chronic hepatitis D. The reported on-treatment virologic response varies between 17 and 47%, with relapses in more than 50% of these patients. No stopping rules have been defined

Externí odkaz: https://doaj.org/article/38b6081795094fa6a3d4e62aee3ae9df

Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy.

Autor: Zhang PX; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China., Zheng XW; Department of Infectious Diseases, Anhui Provincial Hospital, Hefei 230000, Anhui Province, China., Zhang YF; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China., Ye J; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China., Li W; Department of Hepatology, The Second People's Hospital of Fuyang City, Fuyang 236000, Anhui Province, China., Tang QQ; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China., Zhu J; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China., Zou GZ; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China., Zhang ZH; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China. zzh1974cn@163.com.

Publikováno v: World journal of hepatology [World J Hepatol] 2024 Mar 27; Vol. 16 (3), pp. 405-417.

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study.

Autor: Etzion, Ohad^1,2 ohadet@clalit.org.il, Dahari, Harel³ hdahari@luc.edu, Yardeni, David^1,2, Issachar, Assaf^4,5, Nevo-Shor, Anat^1,2, Cohen-Naftaly, Michal^4,5, Ashur, Yaffa⁶, Uprichard, Susan L.³, Arbib, Orly Sneh^4,5, Munteanu, Daniela^1,2, Braun, Marius^4,5, Cotler, Scott J.³, Abufreha, Naim^1,2, Keren-Naus, Ayelet⁷, Shemer-Avni, Yonat⁷, Mor, Orna⁸, Murad, Jayanah⁹, Novack, Victor⁹, Shlomai, Amir^4,5

Publikováno v: Scientific Reports. 10/20/2020, Vol. 10 Issue 1, p1-9. 9p.

Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy

Autor: Lontok, Erik, Mani, Nina, Harrington, Patrick R., Miller, Veronica

Publikováno v: Clinical Infectious Diseases, 2013 May . 56(10), 1466-1470.

Externí odkaz: http://dx.doi.org/10.1093/cid/cit025